| Old Articles: <Older 5891-5900 Newer> |
|---|
 |
The Motley Fool
September 18, 2009
Brian Orelli |
Up, Down, Up. Is This Stock a Home Run or Not? Shares of Arena Pharmaceuticals have been on a roller coaster after word that the company would release data for its obesity drug.   |
The Motley Fool
September 18, 2009
Brian Orelli |
A 25% Stock Gain Will Ease Any Pain Glaxo and XenoPort's shingles drug gives the latter's shares a healthy boost. |
The Motley Fool
September 18, 2009
Brian Orelli |
Hey, Sequenom, That's Great, But ... Investors are still waiting for some real second-quarter news from Sequenom. |
BusinessWeek
September 16, 2009
Catherine Arnst |
The Truth About Malpractice Lawsuits President Barack Obama tapped into a large vein of public support when he suggested recently that he is open to reforming medical malpractice laws. |
Chemistry World
September 17, 2009
Ned Stafford |
Food supplement fights HIV A medical nutritional supplement can slow the decline in immunity in HIV-positive patients, according to clinical trials results presented this week. |
The Motley Fool
September 17, 2009
Charly Travers |
Companies That Will Thrive Under Obamacare They are out there. |
The Motley Fool
September 17, 2009
Brian Orelli |
Baucuscare: Who's Paying? You are -- indirectly, of course. But nobody said reform would be cheap. |
The Motley Fool
September 17, 2009
Brian Orelli |
Sleepless in Sanofi It's nothing but sleepless nights for sanofi-aventis, and there's no drug to cure it. |
The Motley Fool
September 16, 2009
Brian Orelli |
Here Come the Swine Flu Vaccines Drugmakers moved one step closer to getting swine flu vaccines into your arm with approvals by the Food and Drug Administration. |
The Motley Fool
September 15, 2009
Brian Orelli |
What's $115 Million Between Friends? Elan has to fix the mess it had gotten itself into with its multiple sclerosis drug Tysabri. |
| <Older 5891-5900 Newer> Return to current articles. |
